Breast cancer in six women with neurofibromatosis type 1

Breast

Volumn 6, Issue 3, 1997, Pages 155-160

  Teh, B T ^a   Birrell, G ^b   Farrell, A ^c   Leonard, J H ^b   Walters, M K ^c   Palmer, J M ^c   Ramsay, J R ^a   Schlect, D J ^d   Furnival, C ^d   Lavin, M F ^a,c   Bennett, I ^a,e   Hayward, N K ^c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Queensland Radium Institute   (Australia)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d The Wesley Private Hospital   (Australia)

^e NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATAXIA TELANGIECTASIA; BREAST CANCER; CANCER SUSCEPTIBILITY; CHROMOSOME 17Q; CLINICAL ARTICLE; FEMALE; GENE; HUMAN; KARYOTYPING; NEUROFIBROMATOSIS; PRIORITY JOURNAL; RADIOSENSITIVITY;

EID: 12644312209     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(97)90558-0     Document Type: Article

References (33)

1. Crowe F W, Schull W J, Neel J V. The frequency of neurofibroraatosis. In: A clinical, pathological and genetic study of multiple neurofibromatosis. Springfield, IL: CC Thomas, 1956, 142-146.
2. Riccardi V M. Neurofibromatosis: phenotype, natural history and pathogenesis, 2nd ed. Baltimore: Johns Hopkins University Press, 1992.
3. Sorensen S A, Mulvihill J J, Nielsen A. Long-term follow-up of von Recklinghausen neurofibromatosis. N Engl J Med 1986; 314: 1010-1015.
4. Clark S S, Hunter Jr J J. Familial neurofibromatosis and juvenile chronic myelogenous leukemia. Hum Genet 1982; 60: 230-232.
5. Shannon K M, Watterson J, Johnson P et al. Monosomy 7 myeloproliferative disease in children with neurofibromatosis type 1: epidemiology and molecular analysis. Blood 1992; 79: 1311-1318.
6. Matsui I, Tanimura M, Kobayashi N, Sawada T, Nagahara N, Akatsuka J-I. Neurofibromatosis type 1 and childhood cancer. Cancer 1993; 72: 2746-2754.
7. Seizinger B. NF1: a prevalent cause of tumorigenesis in human cancers? Nature Genet 1993; 3: 97-99.
8. Marshall E. Epidemiology. Search for a killer: focus shifts from fat to hormones. Science 1993; 259: 618-621.
9. Brasfield R D, Das Gupta T K. Von Recklinghausen's disease: a clinicopathological study. Ann Surg 1972; 175: 86-104.
10. el-Zawahry M D, Farid M, Abd el-Latif A, Horeia H, el-Gindy M, Twakal G. Breast lesions in generalized neurofibromatosis: Breast cancer and cystosarcoma phylloides. Neurofibromatosis 1989; 2: 121-124.
11. Yoshizawa S, Haga S, Shimizu T, Lida T, Matsumoto N, Kajowara T. A case of breast cancer with Recklinghausen's disease and idiopathic hypertrophic subaortic stenosis. J Tokyo Women's Med Coll 1985; 55: 1080-1084.
12. Miller A B, Howe G R, Sherman G J et al. Mortality from breast cancer after irradiation using fluoroscopic examinations in patients being treated for tuberculosis. N Engl J Med 1989; 321: 1285-1289.
13. Hildreth N G, Shore R E, Dvoretsky P M. The risk of breast cancer after irradiation of the thymus in infants. N Engl J Med 1989; 321: 1281-1284.
14. Mattsson A, Ruden B-I, Hall P, Wilking N, Rutqvist L E. Radiation-induced breast cancer: long-term follow-up of radiation therapy for benign breast disease. J Natl Cancer Inst 1993; 85: 1679-1684.
15. Swift M. Ionizing radiation, breast cancer and ataxia-telangiectasia. J Natl Cancer Inst 1994; 86: 1571-1572.
16. Easton D. Cancer risks in A-T heterozygotes. Int J Rad Biol (Suppl) 1994; 66: S177-S182.
17. Gotoff S P, Amirokri E, Liebner E J. Ataxia-telangiectasia: neoplasia, untoward response to X-irradiation, and tuberous sclerosis. Am J Dis Child 1967; 114: 617-625.
18. Taylor A M R, Harnden D G, Arlett C F et al. Ataxia-telangiectasia: a human mutation with abnormal radiation sensitivity. Nature 1975; 258: 427-429.
19. Savitsky K, Bar-Shira A, Gilad S, et al. A single ataxia-telangiectasia gene with a product similar to PI-3 kinase. Science 1995; 268: 1749-1753.
20. Chen P C, Lavin M F, Kidson C, Moss D J. Identification of ataxia-telangiectasia heterozygotes: a cancer prone population. Nature 1978; 274: 484-486.
21. Natagaran A T, Meijers M, van Zeeland A A, Simons J W. Attempts to detect ataxia-telangiectasia (AT) heterozygotes by cytogenetical techniques. Cytogenet Cell Genet 1982; 33: 145-151.
22. Scott D, Spreadborough A, Levine E, Roberts S A. Genetic predisposition in breast cancer. Lancet 1994; 344: 1444.
23. Arlett C F, Priestly A. An assessment of the radiosensitivity of ataxia telangiectasia heterozygotes. In: Gatti R A, Swift M, eds. Ataxia-telangiectasia: genetics, neuropathology, immunology of a degenerative disease of childhood. New York: Alan R. Liss, 101-109.
24. Shiloh Y, Parshad R, Sanford K K, Jones G M. Carrier detection in ataxia-telangiectasia. Lancet 1986; II; 689-690.
25. Lavin M F, Le Poidevin P, Bates P. Enhanced levels of radiation-induced G2 phase delay in ataxia-telangiectasia heterozygotes. Cancer Genet Cytogenet 1992; 60: 1050-1054.
26. Lavin M F, Bennett I, Ramsay J, Gardiner R A, Seymour G J, Farrell A, Walsh M. Identification of a potentially radiosensitive subgroup among patients with breast cancer. J Natl Cancer Inst 1994; 86: 1627-1634.
27. Neitzel H. A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum Genet 1986; 73: 320-326.
28. Seabright M. A rapid banding technique for human chromosomes. The Lancet 1971; 2: 971-972.
29. Ramsay J R, Birrell G. Normal tissue radiosensitivity in breast cancer patients. Int J Rad Oncol Biol Phys 1995; 31: 339-344.
30. Mossman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 1983; 65: 55-63.
31. Powell S M, Petersen G M, Krush A J et al. Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 1993; 329: 1982-1987.
32. Lagios M. Multicentricity of breast cancer demonstrated by routine correlated aerial subgroups and radiographic examination. Cancer 1977; 40: 1726-1734.
33. Jacquemier J, Eisinger F, Birnbaum D, Sobol H. Histoprognostic grade in BRCA1 associated breast cancer. Lancet 1995; 345: 1503.